| Product Code: ETC4642309 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Infectious Disease Biomarker Testing Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 Netherlands Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Netherlands Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in the Netherlands |
4.2.2 Growing awareness about the importance of early disease detection and diagnosis |
4.2.3 Technological advancements in biomarker testing leading to more accurate and efficient results |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new biomarker tests |
4.3.2 Limited reimbursement policies for biomarker testing in infectious diseases |
4.3.3 High costs associated with developing and commercializing biomarker tests |
5 Netherlands Infectious Disease Biomarker Testing Market Trends |
6 Netherlands Infectious Disease Biomarker Testing Market Segmentations |
6.1 Netherlands Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2021-2031F |
6.1.3 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.1.4 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2021-2031F |
6.2 Netherlands Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2021-2031F |
6.2.3 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2021-2031F |
6.2.4 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2021-2031F |
6.2.5 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2021-2031F |
6.2.6 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2021-2031F |
6.2.7 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2021-2031F |
6.3 Netherlands Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2021-2031F |
6.3.3 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2021-2031F |
6.3.4 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.5 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2021-2031F |
6.3.6 Netherlands Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2021-2031F |
7 Netherlands Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 Netherlands Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 Netherlands Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 Netherlands Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Number of research and development partnerships for biomarker test development |
8.2 Adoption rate of new biomarker testing technologies in healthcare facilities |
8.3 Number of publications or studies validating the effectiveness of biomarker tests in infectious diseases |
9 Netherlands Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 Netherlands Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Netherlands Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Netherlands Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Netherlands Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 Netherlands Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here